Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17
暂无分享，去创建一个
R. Moots | W. Lynn | S. Lightman | O. Tomkins-Netzer | D. Haskard | M. Stanford | H. Longhurst | D. Yang | V. Calder | S. Taylor | C. Bunce | Susan Lightman | Catey Bunce | Virginia L. Calder | Simon R J Taylor | William Lynn | Miles Stanford